Bifogade filer
PDF
Kurs
+3,64%
Likviditet
0,10 MSEK
Kalender
| Est. tid* | ||
| 2025-08-29 | 10:00 | Bokslutskommuniké 2025 |
| 2025-05-15 | N/A | Extra Bolagsstämma 2025 |
| 2025-05-09 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-02-07 | - | Kvartalsrapport 2025-Q2 |
| 2024-11-04 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2024-11-01 | - | Årsstämma |
| 2024-10-28 | - | Kvartalsrapport 2025-Q1 |
| 2024-08-30 | - | Bokslutskommuniké 2024 |
| 2024-04-19 | - | Kvartalsrapport 2024-Q3 |
| 2024-04-12 | - | Extra Bolagsstämma 2024 |
| 2024-02-09 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-27 | - | Kvartalsrapport 2024-Q1 |
| 2023-09-25 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2023-09-22 | - | Årsstämma |
| 2023-08-31 | - | Bokslutskommuniké 2023 |
| 2023-05-04 | - | Kvartalsrapport 2023-Q3 |
| 2023-02-09 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-27 | - | Kvartalsrapport 2023-Q1 |
| 2022-10-07 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2022-10-06 | - | Årsstämma |
| 2022-08-30 | - | Bokslutskommuniké 2022 |
| 2022-07-05 | - | Extra Bolagsstämma 2022 |
| 2022-05-04 | - | Kvartalsrapport 2022-Q3 |
| 2022-02-11 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-22 | - | Kvartalsrapport 2022-Q1 |
| 2021-10-06 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2021-10-05 | - | Årsstämma |
| 2021-08-30 | - | Bokslutskommuniké 2021 |
| 2021-05-12 | - | Kvartalsrapport 2021-Q3 |
| 2021-02-12 | - | Kvartalsrapport 2021-Q2 |
| 2020-11-12 | - | Kvartalsrapport 2021-Q1 |
| 2020-10-08 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2020-10-07 | - | Årsstämma |
| 2020-08-31 | - | Bokslutskommuniké 2020 |
| 2020-05-15 | - | Kvartalsrapport 2020-Q3 |
| 2020-05-04 | - | Extra Bolagsstämma 2020 |
| 2020-02-14 | - | Kvartalsrapport 2020-Q2 |
| 2019-11-01 | - | Kvartalsrapport 2020-Q1 |
| 2019-10-10 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2019-10-09 | - | Årsstämma |
| 2019-08-30 | - | Bokslutskommuniké 2019 |
| 2019-05-16 | - | Kvartalsrapport 2019-Q3 |
| 2019-02-14 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-30 | - | Kvartalsrapport 2019-Q1 |
| 2018-10-17 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2018-10-16 | - | Årsstämma |
| 2018-08-31 | - | Bokslutskommuniké 2018 |
| 2018-05-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-02-14 | - | Kvartalsrapport 2018-Q2 |
| 2017-10-30 | - | Kvartalsrapport 2018-Q1 |
| 2017-10-02 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2017-09-29 | - | Årsstämma |
| 2017-08-30 | - | Bokslutskommuniké 2017 |
| 2017-05-22 | - | Kvartalsrapport 2017-Q3 |
| 2017-02-20 | - | Kvartalsrapport 2017-Q2 |
| 2017-01-25 | - | Extra Bolagsstämma 2017 |
| 2016-11-07 | - | Kvartalsrapport 2017-Q1 |
| 2016-08-29 | - | X-dag ordinarie utdelning VSD B 0.00 SEK |
| 2016-08-26 | - | Bokslutskommuniké 2016 |
| 2016-05-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-02-25 | - | Kvartalsrapport 2016-Q2 |
| 2015-11-26 | - | Kvartalsrapport 2016-Q1 |
| 2015-08-27 | - | Bokslutskommuniké 2015 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Diabetic Foot Screening is introduced at the Insurance Clinic at Sophiahemmet as standard procedure in the clinical operations, for regular control of nerve damage in the feet of people living with diabetes. They are the first private healthcare provider in Sweden to use the method.
The Insurance Clinic Sophiahemmet uses the instrument VibroSense Meter® II and introduces the Diabetic Foot Screening examination as standard procedure in its clinical operations. Existing diagnostics tools, Tuning Fork and Monofilament are thus replaced with Diabetic Foot Screening for conducting foot examinations of people living with diabetes.
"After evaluating the Diabetic Foot Screening in the spring of 2023, we have decided to introduce this examination as a standard procedure for diabetes patients in our clinic. The examination offers clear advantages and detects early sensory changes in the feet, which gives us better opportunities to prevent the development of diabetes-related foot ulcers," says Maarit Korkeila Liden, Operations Manager and Specialist Physician at the Insurance Clinic at Sophiahemmet.
"We are incredibly happy and proud of the collaboration with Insurance Clinic at Sophiahemmet, which is one of the most reputable clinics in Sweden, and also that they have chosen our product and VibroSense as a supplier," says Hans Wallin, CEO of VibroSense Dynamics AB.
Contact
Hans Wallin, CEO VibroSense Dynamics AB
Tel: +46 40 88 026
Email: info@vibrosense.com
www.vibrosense.se
"The new Gold Standard for reliable
detection of nerve damage"
About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.
Our vision is that the company's products should be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.
About Sophiahemmet
Sophiahemmet Hospital offers highly specialized healthcare through around 30 independent healthcare providers in most care areas on behalf of Region Stockholm, some other regions in Sweden and insurance companies. https://sjukhus.sophiahemmet.se/